27 Sep 2018
Lactalis’ acquisition of Aspen’s infant formula division boosts its potential in the Chinese market
By Staff Writer
Following Lactalis’s €740m (US$860.1m) purchase of South African-based pharma giant Aspen’s infant formula division, Fiona Dyer, consumer analyst at GlobalData, a leading data and analytics company, offers her view: